CONTEXTVISION AB (CONTX.OL) Stock Fundamental Analysis
OSL:CONTX - SE0014731154 - Common Stock
4.6 NOK
+0.17 (+3.84%)
Overall CONTX gets a fundamental rating of 6 out of 10. We evaluated CONTX against 11 industry peers in the Health Care Technology industry. Both the health and profitability get an excellent rating, making CONTX a very profitable company, without any liquidiy or solvency issues. CONTX has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
CONTX had positive earnings in the past year.
CONTX had a positive operating cash flow in the past year.
CONTX had positive earnings in 4 of the past 5 years.
CONTX had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
CONTX has a better Return On Assets (10.31%) than 81.82% of its industry peers.
CONTX has a better Return On Equity (14.29%) than 72.73% of its industry peers.
With an excellent Return On Invested Capital value of 12.59%, CONTX belongs to the best of the industry, outperforming 90.91% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CONTX is significantly above the industry average of 9.32%.
The 3 year average ROIC (36.72%) for CONTX is well above the current ROIC(12.59%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 14.29% | ||
| ROIC | 12.59% |
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
1.3 Margins
CONTX has a Profit Margin of 10.66%. This is in the better half of the industry: CONTX outperforms 63.64% of its industry peers.
CONTX's Profit Margin has improved in the last couple of years.
CONTX has a Operating Margin of 12.82%. This is in the better half of the industry: CONTX outperforms 72.73% of its industry peers.
CONTX's Operating Margin has improved in the last couple of years.
CONTX's Gross Margin of 97.41% is amongst the best of the industry. CONTX outperforms 90.91% of its industry peers.
CONTX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.82% | ||
| PM (TTM) | 10.66% | ||
| GM | 97.41% |
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CONTX is creating value.
The number of shares outstanding for CONTX remains at a similar level compared to 1 year ago.
CONTX has about the same amout of shares outstanding than it did 5 years ago.
CONTX has a worse debt/assets ratio than last year.
2.2 Solvency
The Debt to FCF ratio of CONTX is 0.50, which is an excellent value as it means it would take CONTX, only 0.50 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 0.50, CONTX is doing good in the industry, outperforming 72.73% of the companies in the same industry.
A Debt/Equity ratio of 0.08 indicates that CONTX is not too dependend on debt financing.
CONTX has a better Debt to Equity ratio (0.08) than 72.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.5 | ||
| Altman-Z | N/A |
ROIC/WACC1.83
WACC6.89%
2.3 Liquidity
A Current Ratio of 3.66 indicates that CONTX has no problem at all paying its short term obligations.
CONTX has a Current ratio of 3.66. This is amongst the best in the industry. CONTX outperforms 100.00% of its industry peers.
CONTX has a Quick Ratio of 3.59. This indicates that CONTX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.59, CONTX belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.66 | ||
| Quick Ratio | 3.59 |
3. Growth
3.1 Past
CONTX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.32%, which is quite good.
CONTX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 40.02% yearly.
Looking at the last year, CONTX shows a quite strong growth in Revenue. The Revenue has grown by 12.19% in the last year.
CONTX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.78% yearly.
EPS 1Y (TTM)14.32%
EPS 3Y40.02%
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)12.19%
Revenue growth 3Y11.74%
Revenue growth 5Y7.78%
Sales Q2Q%-12.48%
3.2 Future
CONTX is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.74% yearly.
The Revenue is expected to decrease by -0.20% on average over the next years.
EPS Next Y-28.88%
EPS Next 2Y-26.55%
EPS Next 3Y-5.88%
EPS Next 5Y0.74%
Revenue Next Year-5.88%
Revenue Next 2Y-4.51%
Revenue Next 3Y-2.08%
Revenue Next 5Y-0.2%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
CONTX is valuated reasonably with a Price/Earnings ratio of 10.22.
90.91% of the companies in the same industry are more expensive than CONTX, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of CONTX to the average of the S&P500 Index (27.44), we can say CONTX is valued rather cheaply.
A Price/Forward Earnings ratio of 19.13 indicates a rather expensive valuation of CONTX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CONTX indicates a somewhat cheap valuation: CONTX is cheaper than 72.73% of the companies listed in the same industry.
CONTX is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.87, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.22 | ||
| Fwd PE | 19.13 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CONTX indicates a somewhat cheap valuation: CONTX is cheaper than 63.64% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CONTX is valued a bit cheaper than the industry average as 72.73% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.46 | ||
| EV/EBITDA | 11 |
4.3 Compensation for Growth
The excellent profitability rating of CONTX may justify a higher PE ratio.
CONTX's earnings are expected to decrease with -5.88% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-26.55%
EPS Next 3Y-5.88%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.18%, CONTX is a good candidate for dividend investing.
CONTX's Dividend Yield is rather good when compared to the industry average which is at 3.59. CONTX pays more dividend than 81.82% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.45, CONTX pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.18% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y-26.55%
EPS Next 3Y-5.88%
OSL:CONTX (9/11/2025, 3:01:07 PM)
4.6
+0.17 (+3.84%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners10.82%
Inst Owner ChangeN/A
Ins Owners24%
Ins Owner ChangeN/A
Market Cap355.90M
Analysts40
Price Target5.1 (10.87%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.18% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-9.09%
PT rev (3m)-9.09%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-46.34%
EPS NY rev (3m)-46.34%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.22 | ||
| Fwd PE | 19.13 | ||
| P/S | 2.74 | ||
| P/FCF | 17.46 | ||
| P/OCF | 12.85 | ||
| P/B | 3.68 | ||
| P/tB | 3.81 | ||
| EV/EBITDA | 11 |
EPS(TTM)0.45
EY9.78%
EPS(NY)0.24
Fwd EY5.23%
FCF(TTM)0.26
FCFY5.73%
OCF(TTM)0.36
OCFY7.78%
SpS1.68
BVpS1.25
TBVpS1.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 14.29% | ||
| ROCE | 15.94% | ||
| ROIC | 12.59% | ||
| ROICexc | 44.69% | ||
| ROICexgc | 50.4% | ||
| OM | 12.82% | ||
| PM (TTM) | 10.66% | ||
| GM | 97.41% | ||
| FCFM | 15.71% |
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
ROICexc(3y)120.16%
ROICexc(5y)134.4%
ROICexgc(3y)169.64%
ROICexgc(5y)243.25%
ROCE(3y)46.47%
ROCE(5y)60.03%
ROICexcg growth 3Y-39.35%
ROICexcg growth 5Y-1.08%
ROICexc growth 3Y-26.11%
ROICexc growth 5Y14.23%
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
F-Score4
Asset Turnover0.97
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.5 | ||
| Debt/EBITDA | 0.29 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 107.84% | ||
| Profit Quality | 147.45% | ||
| Current Ratio | 3.66 | ||
| Quick Ratio | 3.59 | ||
| Altman-Z | N/A |
F-Score4
WACC6.89%
ROIC/WACC1.83
Cap/Depr(3y)55.3%
Cap/Depr(5y)58.55%
Cap/Sales(3y)3.81%
Cap/Sales(5y)5.04%
Profit Quality(3y)103.4%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.32%
EPS 3Y40.02%
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y-28.88%
EPS Next 2Y-26.55%
EPS Next 3Y-5.88%
EPS Next 5Y0.74%
Revenue 1Y (TTM)12.19%
Revenue growth 3Y11.74%
Revenue growth 5Y7.78%
Sales Q2Q%-12.48%
Revenue Next Year-5.88%
Revenue Next 2Y-4.51%
Revenue Next 3Y-2.08%
Revenue Next 5Y-0.2%
EBIT growth 1Y-60.97%
EBIT growth 3Y-12.49%
EBIT growth 5Y8.23%
EBIT Next Year-3.57%
EBIT Next 3Y20.51%
EBIT Next 5YN/A
FCF growth 1Y-35.26%
FCF growth 3Y82.69%
FCF growth 5Y67.13%
OCF growth 1Y-34.27%
OCF growth 3Y51.49%
OCF growth 5Y5.6%